Latest Updates
R2 Technologies Earns Third FDA Indication
San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.
R2 Technologies Earns Third FDA Indication
San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.
Latest Science
Nail Fungus: Embarrassing. Ugly. Dangerous.
Nail fungus, or onychomycosis, is a familiar problem that’s often seen as little more than an unsightly and hard to treat cosmetic issue. But for many of the millions of people worldwide who are affected by this under-treated condition, the impact may be far greater — and far more serious.
Latest News
R2 Technologies Earns Third FDA Indication
San Ramon, California: R2 Technologies Inc. (“R2”), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry.
On The Road: 2020 Dermatology Innovation Forum
Blossom is headed to the 2020 Dermatology Innovation Forum.
Blossom Innovations Wins Prestigious IMCAS’ Innovation of the Year Award
Blossom Innovations wins innovation award at 2020 IMCAS World Congress.
